[1]刘媛媛,刘万敏.中药对缺血性脑血管病的防治作用[J].医学信息,2022,35(21):171-173.[doi:10.3969/j.issn.1006-1959.2022.21.046]
　LIU Yuan-yuan,LIU Wan-min.Preventive Effect of Chinese Medicine on Ischemic Cerebrovascular Disease[J].Journal of Medical Information,2022,35(21):171-173.[doi:10.3969/j.issn.1006-1959.2022.21.046]
点击复制

中药对缺血性脑血管病的防治作用()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年21期
页码:
171-173
栏目:
综述
出版日期:
2022-11-01

文章信息/Info

Title:
Preventive Effect of Chinese Medicine on Ischemic Cerebrovascular Disease
文章编号:
1006-1959（2022）21-0171-03
作者:
刘媛媛; 刘万敏
（联勤保障部队天津康复疗养中心中医针灸康复科，天津 300381）
Author(s):
LIU Yuan-yuan; LIU Wan-min
(Department of TCM Acupuncture Rehabilitation,Center of Rehabilitation and Recuperation in Joint Service Support Force ofChinese People’s Liberation Army,Tianjin 300381,China)
关键词:
缺血性脑血管病; 中药; 动脉粥样硬化; 痰瘀互结; 脑卒中; 肝脾肾气虚
Keywords:
Ischemic cerebrovascular disease; Traditional Chinese medicine; Atherosclerosis; Phlegm and blood stasis; Stroke; Liver;  spleen and kidney qi deficiency
分类号:
R277.7
DOI:
10.3969/j.issn.1006-1959.2022.21.046
文献标志码:
A
摘要:
缺血性脑血管病是神经外科常见综合征，其病因繁多、治疗困难，常伴有较高的致残、致死风险，是导致我国中老年人死亡的重要危险因素，因此，寻求有效防治措施尤为重要。近年来，中医药在缺血性脑血管病防治的应用中取得了可喜进展，其方案具有多环节、多靶点、多途径等特点，可借助中医辨证论治原则，灵活运用活血、化痰、疏肝、健脾、补肾、解毒等方式，实现标本兼治、内外同调的目的，且安全性高，为缺血性脑血管病的治疗提供了新的临床思路。基于此，本文将近年来的相关研究进行综述，以期为缺血性脑血管病的临床治疗提供一定参考依据。
Abstract:
Ischemic cerebrovascular disease is a common syndrome in neurosurgery. It has many causes and is difficult to treat. It is often accompanied by a high risk of disability and death. It is an important risk factor for the death of middle-aged and elderly people in China. Therefore, it is particularly important to seek effective prevention and treatment measures. In recent years, the application of traditional Chinese medicine in the prevention and treatment of ischemic cerebrovascular disease has made gratifying progress. The scheme has the characteristics of multi-link, multi-target and multi-channel. With the help of the principle of syndrome differentiation and treatment of traditional Chinese medicine, it can flexibly use the methods of activating blood circulation, resolving phlegm, soothing liver, invigorating spleen, tonifying kidney and detoxification, so as to achieve the purpose of treating both symptoms and root causes, internal and external coordination, and high safety, which provides a new clinical idea for the treatment of ischemic cerebrovascular disease. Based on this, this paper reviews the related research in recent years, in order to provide some reference for the clinical treatment of ischemic cerebrovascular disease.

参考文献/References:

[1]Lin K,Chen L,Wang Y,et al.Endovascular treatment of cerebrovascular stenosis with stent for patients with ischemic cerebrovascular disease[J].Medicine (Baltimore),2020,99(47):e23313.[2]Ikeda-Sakai Y,Sasaki M,Nakase T.Effects With and Without Clopidogrel Loading Treatment for Acute Ischemic Cerebrovascular Disease Patients: A Retrospective Cohort Study[J].J Stroke Cerebrovasc Dis,2017,26(12):2901-2908.[3]Yang J,Lyu Y,Ma Y,et al.Relationship between cerebral microbleeds location and cognitive impairment in patients with ischemic cerebrovascular disease[J].Neuroreport,2018,29(14):1209-1213.[4]朱琳,姚明,周立新,等.青年缺血性卒中病因诊断的性别差异研究[J].中风与神经疾病杂志,2020,37(8):689-693.[5]井晓煦,师会.平肝活血法治疗后循环缺血性眩晕30例[J].河南中医,2016,36(12):2173-2175.[6]黄循夫,万兴富.活血荣络汤治疗缺血性中风阴虚血瘀证的临床观察[J].中医药导报,2017,23(22):91-93.[7]牛永义,王芸生.清热熄风活血汤合葛根素注射液治疗急性脑梗死风阳上扰证疗效观察[J].安徽医药,2020,24(1):27-32.[8]魏瑞丽,谢雁鸣,王连心,等.清开灵注射液治疗缺血性脑血管病患者真实世界临床特征及联合用药分析[J].中南药学,2016,14(12):1287-1292.[9]陆昕,郭永娟,周华,等.血脂与阴虚体质-亚健康-缺血性卒中演变规律的相关性研究[J].四川中医,2016,34(1):65-67.[10]张志良,安洪泽,崔建杰,等.化湿解毒通络汤治疗缺血性脑卒中临床疗效研究[J].河北中医药学报,2016,31(1):54-56.[11]赵碎巧,操银针,李信华,等.通络化痰胶囊联合阿托伐他汀对急性脑梗死病人血小板聚集度及炎性因子水平的影响[J].中西医结合心脑血管病杂志,2016,14(7):685-687.[12]刘东坡.化痰通络汤对脑梗死患者颈动脉粥样硬化斑块、血脂及不稳定标志物MMP-9、TIMP-1水平的影响[J].中医学报,2017,32(12):2472-2476.[13]迟海涛,白鹰,单淑珍,等.通络化痰胶囊联合胞二磷胆碱治疗急性脑梗死的临床研究[J].现代药物与临床,2019,34(12):3568-3572.[14]陈刚.活血通络化痰中药对缺血性脑中风患者临床疗效及血清HCY、CRP、SOD、MDA的影响[J].标记免疫分析与临床,2017,24(6):627-630.[15]李春雷,张峰,黄川锋.血塞通注射液联合苏合香丸治疗脑梗死急性期的临床研究[J].中国临床药理学杂志,2016,32(15):1350-1352,1366.[16]王辉.自拟益气活血方联合西医治疗缺血性脑卒中恢复期的综合疗效探究[J].中国临床医生杂志,2016,44(10):97-99.[17]刘月秋,刘辉,杜卫.益气活血通络汤治疗缺血性脑中风疗效观察[J].世界中医药,2017,12(1):42-44,48.[18]任胜洪,柯绍兴,石燕芳,等.益气活血法治疗缺血性脑卒中的疗效及其对患者颈动脉粥样硬化斑块的影响[J].海南医学,2017,28(9):1398-1400.[19]王成太.益气活血法治疗缺血性脑卒中恢复期患者的临床疗效及对hs-CRP、Fg、HCY水平的影响[J].实用临床医药杂志,2016,20(3):28-31.[20]孟祥博,石焱,陈天笑,等.益气活血方联合康复锻炼对缺血性脑卒中患者运动功能、平衡力及日常生活能力的影响[J].中华中医药学刊,2017,35(12):3179-3181.[21]钟银玲,李花,刘旺华,等.健脾补土法组方对脑缺血/再灌注损伤大鼠脑组织t-PA、PAI-1、Col Ⅳ的影响[J].中国中医急症,2016,25(12):2213-2215,2267.[22]赵心想,苑海霞,宋彩霞,等.半夏白术天麻汤治疗缺血性脑卒中急性期患者的临床疗效及其对凝血功能、脑血流动力学的影响[J].实用心脑肺血管病杂志,2019,27(4):59-63.[23]王红娟.平肝健脾补肾法治疗后循环缺血性眩晕疗效及对血流动力学的影响[J].现代中西医结合杂志,2017,26(8):840-842.[24]张涛军,刘向哲,冯晓东,等.磁共振灌注加权成像观察健脾补肾活血方结合运动疗法对脑梗死患者缺血区血液循环的影响[J].中国康复理论与实践,2018,24(5):513-516.[25]朱江,郭森,赵亮,等.健脾熄风活络汤治疗急性缺血性脑卒中复发疗效及对患者神经功能的影响[J].陕西中医,2020,41(6):740-742.[26]胡丹,盛蕾.加味柴胡疏肝颗粒辅助治疗缺血性脑卒中后抑郁的疗效观察[J].中草药,2016,47(21):3866-3870.[27]殷敏,杨建梅,张慧,等.陈氏糖肾方合用脑脉泰胶囊对糖尿病肾病合并缺血性脑卒中患者血清同型半胱氨酸及相关因子的影响[J].中国医刊,2016(6):82-85.[28]吴建明,王玮,付伟,等.舒肝解郁胶囊对实验性缺血脑卒中的防治作用[J].华西药学杂志,2016,31(1):45-47.[29]裴晋云,陈红霞.疏肝解郁法结合康复训练对脑卒中后偏瘫患者运动功能、日常生活活动能力和生活质量的影响[J].世界中西医结合杂志,2017,12(3):381-385.[30]柯娟,袁梦果,过伟峰.补肾平肝法治疗后循环缺血性眩晕经验与体会[J].浙江中医药大学学报,2017,41(8):688-691.[31]王建伟,郭蓉娟,刘雪梅,等.从NOX4与炎性因子角度探讨清热、活血组分联用治疗缺血性脑卒中火毒证大鼠脑组织损伤的机制[J].北京中医药,2017,36(7):594-599.[32]么明玉,刘淑凤.中药清热养阴活血法提升脂联素水平、防治颈动脉粥样斑块临床观察[J].国际心血管病杂志,2017,44(A01):142-142.[33]叶普法,应丹松,柯宁珠.清热凉血通瘀汤加减辅助治疗缺血性脑卒中急性期临床疗效[J].辽宁中医杂志,2016,43(3):536-538.[34]王涛,刘宏祥,王颖,等.早期应用清热化痰解毒汤对实验性缺血性脑卒中大鼠缺损神经的影响[J].河北医药,2018,40(9):1311-1314,1318.[35]蒋媛静,罗宁.基于因子分析缺血性中风恢复期合并脑微出血的中医证候要素研究[J].中国中医急症,2019,28(2):236-239.

相似文献/References:

[1]闫博阳.丁基苯酞软胶囊治疗缺血性脑血管疾病的疗效分析[J].医学信息,2018,31(05):131.[doi:10.3969/j.issn.1006-1959.2018.05.046]
　YAN Bo-yang.Analysis of Curative Effect of Butylphthalide Soft Capsule on Ischemic Cerebrovascular Disease[J].Journal of Medical Information,2018,31(21):131.[doi:10.3969/j.issn.1006-1959.2018.05.046]
[2]邱梦君,郑国荣.大黄、黄连、黄芩联合三联序贯治疗Hp感染的疗效分析[J].医学信息,2018,31(06):137.[doi:10.3969/j.issn.1006-1959.2018.06.047]
　QIU Meng-jun,ZHENG Guo-rong.Curative Effect Analysis of Sequential Treatment of Hp Infection by Rhubarb,Coptis Chinensis and Radix Scutellariae[J].Journal of Medical Information,2018,31(21):137.[doi:10.3969/j.issn.1006-1959.2018.06.047]
[3]黄幼玲.中药配合鹿瓜多肽治疗股骨头坏死临床效果观察[J].医学信息,2018,31(06):141.[doi:10.3969/j.issn.1006-1959.2018.06.049]
　HUANG You-ling.Clinical Observation on Treatment of Femoral Head Necrosis with Chinese Medicine Combined with Lugua Polypeptide[J].Journal of Medical Information,2018,31(21):141.[doi:10.3969/j.issn.1006-1959.2018.06.049]
[4]赵一丹,杨 静.夏枯草主要化学成分抗肺癌作用机制研究进展[J].医学信息,2022,35(09):42.[doi:10.3969/j.issn.1006-1959.2022.09.010]
　ZHAO Yi-dan,YANG Jing.Research Progress on Anti-lung Cancer Mechanism of Main Chemical Constituents of Spica Prunellae[J].Journal of Medical Information,2022,35(21):42.[doi:10.3969/j.issn.1006-1959.2022.09.010]
[5]李 扬,冯 旭,宋 舸,等.中药药性的研究方法进展[J].医学信息,2018,31(13):38.[doi:10.3969/j.issn.1006-1959.2018.13.012]
　LI Yang,FENG Xu,SONG GE,et al.Progress in Research Methods of Medicinal Properties of Traditional Chinese Medicine[J].Journal of Medical Information,2018,31(21):38.[doi:10.3969/j.issn.1006-1959.2018.13.012]
[6]王慧明,卓春萍,王庆雷,等.钢板内固定术联合中药煎服治疗胫骨平台骨折的 临床疗效观察[J].医学信息,2018,31(14):110.[doi:10.3969/j.issn.1006-1959.2018.14.032]
　WANG Hui-ming,ZHUO Chun-ping,WANG Qing-lei,et al.Clinical Observation on Treatment of Fracture of Tibial Plateau with Plate Internal Fixation Combined with Traditional Chinese Medicine Decoction[J].Journal of Medical Information,2018,31(21):110.[doi:10.3969/j.issn.1006-1959.2018.14.032]
[7]郑 瑜.人血白蛋白联合中药治疗卵巢过度刺激综合征患者的疗效观察[J].医学信息,2019,32(04):151.[doi:10.3969/j.issn.1006-1959.2019.04.049]
　ZHENG Yu.Therapeutic Effect of Human Serum Albumin Combined with Traditional Chinese Medicine on Patients with Ovarian Hyperstimulation Syndrome[J].Journal of Medical Information,2019,32(21):151.[doi:10.3969/j.issn.1006-1959.2019.04.049]
[8]马 帅,李家斌.药物性肝损伤的临床分析[J].医学信息,2019,32(03):128.[doi:10.3969/j.issn.1006-1959.2019.03.041]
　MA Shuai,LI Jia-bin.Clinical Analysis of Drug-induced Liver Injury[J].Journal of Medical Information,2019,32(21):128.[doi:10.3969/j.issn.1006-1959.2019.03.041]
[9]吴 迪,柴仲秋,周 冰.靶向癌蛋白调控Warburg效应的中医药研究进展[J].医学信息,2022,35(13):42.[doi:10.3969/j.issn.1006-1959.2022.13.008]
　WU Di,CHAI Zhong-qiu,ZHOU Bing.Research Progress of Traditional Chinese Medicine Targeting Oncoproteins to Regulate Warburg Effect[J].Journal of Medical Information,2022,35(21):42.[doi:10.3969/j.issn.1006-1959.2022.13.008]
[10]严文文,陈 然,金 平,等.老年患者颅内动脉粥样硬化性狭窄的分布和危险因素研究[J].医学信息,2019,32(09):78.[doi:10.3969/j.issn.1006-1959.2019.09.025]
　YAN Wen-wen,CHEN Ran,JIN Ping,et al.Distribution and Risk Factors of Intracranial Atherosclerotic Stenosis in Elderly Patients[J].Journal of Medical Information,2019,32(21):78.[doi:10.3969/j.issn.1006-1959.2019.09.025]

更新日期/Last Update: 1900-01-01